Optex Systems expands board to 5, elects Dayton Judd as director

Optex Systems Holdings Inc

Board expanded from 4 to 5 members; Dayton Judd elected effective Oct 19, 2022.
Judd is founder/managing partner of Sudbury Capital Management and CEO/Chairman of FitLife Brands.
Judd beneficially owns 829,383 shares (12.3% of outstanding), mostly via Sudbury Capital Fund.
He will be compensated under non-employee director compensation practices.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dayton Judd

Director

OPXS · Optex Systems Holdings Inc

Effective: 2022-10-19
Filed: October 25, 2022, 7:59 PM ET

On October 19, 2022, the Board of Directors (the “Board”) of Optex Systems Holdings, Inc., a Delaware corporation (the “Company”), expanded the size of the Board from four to five members and elected Mr. Dayton Judd as a director, to hold office until the Company’s next annual meeting of shareholders and until his successor has been elected and qualified.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dayton Judd was elected as Director at Optex Systems Holdings Inc.

Action: elected
Role: Director

Exact text from the filing

On October 19, 2022, the Board of Directors (the “Board”) of Optex Systems Holdings, Inc., a Delaware corporation (the “Company”), expanded the size of the Board from four to five members and elected Mr. Dayton Judd as a director, to hold office until the Company’s next annual meeting of shareholders and until his successor has been elected and qualified.

View on SEC.gov

Optex Systems Holdings Inc filing history →

Source: SEC EDGAR

accession 0001493152-22-029517

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.